Cytarabine MKII-IN-1 33-decaoxadecacyclo[39

33-decaoxadecacyclo[39

is efficacious therapy for microbiologically proven chancroid in patients who do not have concurrent HIV-1 infection

ClH/c1-9-4-3-5-11(10(9)2)6-12-7-13-8-14-12

CN1CCCN(CC1)C(=O)C1=CC(=CC=C1)C1=CC=C(/C=C2\C3=CC(Cl)=CC=C3NC\2=O)O1

and constipation associated with irritable bowel syndrome

Cytarabine MKII-IN-1 33-decaoxadecacyclo[39Cytarabine is a pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. Product information CAS Number: 147 94 4 Molecular Weight: 243. 22 Formula: C9H13N3O5 Synonym: Cytosine D